Kirkland & Ellis advised private equity firm Olympus Partners on the acquisition of PAI Pharma, the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose cups and bottles in the United States. The transaction was announced February 13, 2025. Financial details were not disclosed.
The Kirkland team included corporate lawyers Matt Goulding and Matt Dunnet; debt lawyers Dan Clayman, Judah Batist and Omar Raddawi; and tax lawyers Tom Evans and Roger Lucas.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
